SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-19-000045
Filing Date
2019-11-08
Accepted
2019-11-08 14:59:28
Documents
91
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20190930x10q.htm   iXBRL 10-Q 1683214
2 EXHIBIT 31.1 supn-20190930x10qxex311.htm EX-31.1 11967
3 EXHIBIT 31.2 supn-20190930x10qxex312.htm EX-31.2 12729
4 EXHIBIT 32.1 supn-20190930x10qxex321.htm EX-32.1 5892
5 EXHIBIT 32.2 supn-20190930x10qxex322.htm EX-32.2 5918
11 a3q1910qmdacurrentportfolioa.jpg GRAPHIC 34807
  Complete submission text file 0001356576-19-000045.txt   7255455

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20190930.xsd EX-101.SCH 52488
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20190930_cal.xml EX-101.CAL 100083
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20190930_def.xml EX-101.DEF 190122
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20190930_lab.xml EX-101.LAB 634940
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20190930_pre.xml EX-101.PRE 361717
62 EXTRACTED XBRL INSTANCE DOCUMENT supn-20190930x10q_htm.xml XML 1219614
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 191203745
SIC: 2834 Pharmaceutical Preparations